SCHEMBL3482676

SCHEMBL3482676

CCCCOCC(C)N1C(=O)C=CC1=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 7/20 0.38
PTGS1 P23219 3/20 0.38
PTGS2 P35354 3/20 0.38
FAAH O00519 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.33
SPHK1 Q9NYA1 1/20 0.33
USP2 O75604 1/20 0.33
GMNN O75496 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
THPO P40225 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HTT P42858 1/20 0.32
TSHR P16473 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5075511 0.87 MGLL (0.42) MGLLGMNNALDH1A1LMNAMAPT
SCHEMBL11932954 0.85 ALDH1A1 (0.32) MGLLALDH1A1
SCHEMBL5081930 0.83 MGLL (0.36) MGLLFAAHSMN1; SMN2GMNNALDH1A1
SCHEMBL10147999 0.82 MGLL (0.37) MGLLPTGS1PTGS2FAAHGMNN
SCHEMBL10297379 0.81 MGLL (0.37) MGLLALDH1A1KDM4E
SCHEMBL10075516 0.81 MGLL (0.33) MGLLALDH1A1BLMTSHR
SCHEMBL16786513 0.77 ALDH1A1 (0.38) MGLLGMNNALDH1A1LMNAMAPT
SCHEMBL21082756 0.77 MGLL (0.65) MGLLPTGS1PTGS2FAAHSMN1; SMN2
SCHEMBL1535492 0.76 MGLL (0.44) MGLLPTGS1PTGS2FAAHSMN1; SMN2
SCHEMBL28884160 0.75 SMN1; SMN2 (0.47) MGLLPTGS1PTGS2FAAHSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420764-B2 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2013-04-16 US disclosed
US-8236917-B2 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2012-08-07 US disclosed
US-20120178894-A1 COMPOUND HAVING SILSESQUIOXANE SKELETON AND ITS POLYMER INAGAKI JYUN-ICHI (JP) 2012-07-12 US disclosed
US-20100240855-A1 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2010-09-23 US disclosed
US-7705105-B2 A cyclic polymer of silsesquioxane skeleton with side chains formed byhydrosilation of an unsaturated end group containing an active polymerfunctional group; polyimidesiloxane copolymers; polyestersiloxane copolymers; high molecular weight; thin films; strength; heat resistance;waterproofing; CHISSO PETROCHEMICAL CORPORATION (JP) 2010-04-27 US disclosed
US-20070190344-A1 Verification of translation JNC CORPORATION (JP) 2007-08-16 US disclosed
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer CHISSO CORPORATION (JP) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer C1S, H1-4, H1-0 MGLL 4700/4885PTGS1 1102/4885PTGS2 2594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.